Mounting calls among frontier technology laboratories to coordinate a slowdown in model deployment are running headlong into a formidable legal barrier: the rigorous framework of competition law. While developers may genuinely worry about unconstrained artificial intelligence creating catastrophic hazards, competing businesses that jointly agree to curb progress quickly trigger scrutiny under the Sherman Act. That landmark statute was engineered to protect open competition and consumer welfare, meaning that any shared pact to restrict output, even under the banner of responsible innovation, risks being classified by federal regulators as a market-distorting cartel rather than an act of civic duty.
The Traps of Corporate Language in Antitrust Scrutiny
In the eyes of competition authorities, the internal phrasing used to describe strategic choices often carries as much legal weight as the operational choices themselves. Google provided a famous historical template by training its staff never to adopt colloquial jargon that implied anti-competitive behavior, directing teams to frame corporate shifts around consumer benefits and improved product quality. By contrast, when artificial intelligence developers openly float notions of an intentional pause or an industry-wide slowdown, they unwittingly activate classical warning lights for market regulators. An unapproved mutual understanding to moderate the cadence of commercial releases can easily be interpreted by enforcement bodies as an illegal restraint of trade.
John Bergmayer, legal counsel at the advocacy group Public Knowledge, argues that these laboratories effectively backed themselves into an avoidable corner through clumsy framing. In conventional antitrust economics, a central inquiry revolves around whether competitors are intentionally diminishing commercial output or entering an informal pact to ease market rivalry. Rather than proposing a collective deceleration that sounds suspiciously collusive, participating companies could have framed their cooperation strictly around defining shared safety benchmarks. Under that narrative, any subsequent delay in shipping advanced systems would simply appear as an organic byproduct of rigorous safety testing rather than an explicit agreement to hold back supply.
Mark Zuckerberg and the Market Logic of Safe Deployment
Meta Chief Executive Mark Zuckerberg, whose enterprise recently evaded a sweeping Federal Trade Commission enforcement action, took an entirely different line by rejecting any explicit slowdown pact. Zuckerberg asserted that artificial intelligence creators already possess an inherent commercial motive to ensure their autonomous agents behave predictably. When software acts outside human expectations, an industry pathology termed misalignment, customers inevitably refuse to use the product. Developers who neglect safety alignment will simply lose market share to more dependable rivals. The scenario mirrors competing automakers: it is legally perilous to agree not to manufacture superior vehicles for a season, but entirely rational to hold back high-velocity cars until brake systems are proven safe, since lethal products find no buyers.
Former Department of Justice Antitrust Division policy director David Lawrence noted on LinkedIn that mutual understandings aimed at neutralizing existential or catastrophic threats actually enhance overall economic output and sustain competition. Under existing jurisprudence, such safeguards can find shelter under the ancillary restraints doctrine. Responding directly to that analysis, a veteran antitrust attorney at the FTC observed that if humanity itself is extinguished, the very concept of market competition becomes entirely irrelevant.
The Risks of Quality Fixing and Precedents in Self-Regulation
Notre Dame Law School professor Roger Alford, formerly a senior official within the Justice Department's Antitrust Division, points out that agreeing to forego safety measures could spark separate allegations of quality fixing. This violation occurs when direct market rivals strike an agreement to halt technical enhancements beyond minimum requirements. Alford cited an instructive European antitrust enforcement action where automotive manufacturers collaborated on vehicle emissions technology but agreed not to compete over cleaner, higher-standard systems. That coordination culminated in financial penalties totaling roughly one billion dollars.
Formal mechanisms for industry cooperation already exist without needing informal pacts. Bergmayer highlights the National Cooperative Research and Production Act of 1993, a federal framework enabling commercial rivals to form standards-development bodies with limited antitrust liability, provided they formally notify the Justice Department and the FTC. Nonetheless, aggressive antitrust enforcers routinely harbor skepticism toward statutory exemptions. Regulators fear that special legal carveouts solidify incumbent advantages, insulate dominant enterprises from market discipline, and effectively choke off access for emerging startups.
Public Offerings, Commercial Rivalries, and Political Headwinds
External resistance to special exemptions has already surfaced across policy circles. David Sacks, co-chair of the President's Council of Advisors on Science and Technology, sharply denounced Anthropic and OpenAI as an emerging duopoly, dismissing their calls for antitrust immunity as an election-season psychological operation intended to erect a private cartel. Yet inside these cutting-edge laboratories, rank-and-file staff have repeatedly voiced authentic alarms regarding the breakneck tempo of deployment. Bergmayer suggests that while firms sometimes seek statutory regulation to lock out newcomers, leadership teams also face intense investor demands, feeling powerless to decelerate unilaterally without crashing impending public listings.
Both OpenAI and Anthropic have privately filed registration paperwork for initial public offerings, each commanding valuations approaching or surpassing the one trillion dollar threshold. Anthropic appears poised to access public markets next month, whereas OpenAI Chief Executive Sam Altman recently announced a postponement of their public offering until 2027 to address pressing safety hurdles, a timeline consistent with earlier guidance provided by the firm's chief financial officer to staff. Tracking metrics from the Ramp AI Index indicate that both entities command comparable enterprise adoption levels and are engaged in a fierce contest for market primacy. Alford observes that neither participant wants to disarm unilaterally while its primary adversary continues surging forward at full speed.
Political realities further complicate any appetite for industrial moderation. Following revelations of the slowdown discussions, Donald Trump declared on social media that the federal government retains tremendous criminal and regulatory power over tech companies, adding that whoever wins the artificial intelligence race wins the future. The chief technology officer account at the Department of Defense has similarly distributed memes dismissing safety alarmism in favor of uninhibited progress. The regulatory apparatus itself remains heavily politicized; Alford was removed from the Justice Department last year after characterizing an agency-approved tech infrastructure merger as a corrupt scandal, while FTC Chair Andrew Ferguson told antitrust conference delegates that Trump would ultimately dictate national policy for the sector.
The Threat of Protracted Conduct Inquiries
Should federal watchdogs choose to open a formal inquiry into a coordinated technological slowdown, the probe would take the shape of a conduct investigation. Unlike merger reviews that operate under rigid statutory calendars, conduct investigations often drag on for multiple years without resolution. Targeted tech firms could be forced to surrender millions of internal documents, top executives would endure grueling depositions, and hundreds of engineering staff would find their daily communications trapped under strict litigation holds, even if prosecutors ultimately decline to file charges. Denied an explicit antitrust exemption and lacking formal regulatory guardrails, leading artificial intelligence developers must navigate a precarious path, attempting to institutionalize safety protocols without becoming ensnared in extensive antitrust litigation.
